Search research articles
Contact Us
Filters
Showing results (551-560 of 583) with videos related to
Page
of 59
Sort By:
Blood Advances
|
October 19, 2023
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy
Lauren C Peres, Laura B Oswald, Christen M Dillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2017
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation
Robert J Soiffer, Haesook T Kim, Joseph McGuirk, et al.
Transplantation and Cellular Therapy
|
February 12, 2023
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials
Chenyu Lin, Aurelie Schwarzbach, Jaime Sanz, et al.
Blood
|
October 4, 2024
Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma
Surbhi Sidana, Krina K Patel, Lauren C Peres, et al.
Bone Marrow Transplantation
|
March 2, 2025
Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study
Mohamed A Kharfan-Dabaja, Razan Mohty, Neela Easwar, et al.
Journal of Experimental Neurology
|
September 22, 2025
Protein Assembly Modulation: A New Approach to Amyotrophic Lateral Sclerosis (ALS) Therapeutics
Shao Feng Yu, Kumar Paulvannan, Dennis Solas, et al.
Blood Cancer Journal
|
December 5, 2024
Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
Maximilian Merz, Danai Dima, Hamza Hashmi, et al.
Blood Advances
|
August 28, 2025
Safety and Efficacy of BCMA directed Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Plasma Cell Leukemia
Gliceida M Galarza Fortuna, Lauren C Peres, Elena Nazarenko, et al.
Blood Advances
|
April 7, 2023
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions
Ajay Major, Jovian Yu, Navika Shukla, et al.
Nature Medicine
|
December 18, 2021
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nathan Hale Fowler, Michael Dickinson, Martin Dreyling, et al.
Page
of 59
Search research articles
Search
Showing results (551-560 of 583) with videos related to
Sort By:
Page
of 59
Blood Advances
|
October 19, 2023
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy
Lauren C Peres, Laura B Oswald, Christen M Dillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2017
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation
Robert J Soiffer, Haesook T Kim, Joseph McGuirk, et al.
Transplantation and Cellular Therapy
|
February 12, 2023
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials
Chenyu Lin, Aurelie Schwarzbach, Jaime Sanz, et al.
Blood
|
October 4, 2024
Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma
Surbhi Sidana, Krina K Patel, Lauren C Peres, et al.
Bone Marrow Transplantation
|
March 2, 2025
Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study
Mohamed A Kharfan-Dabaja, Razan Mohty, Neela Easwar, et al.
Journal of Experimental Neurology
|
September 22, 2025
Protein Assembly Modulation: A New Approach to Amyotrophic Lateral Sclerosis (ALS) Therapeutics
Shao Feng Yu, Kumar Paulvannan, Dennis Solas, et al.
Blood Cancer Journal
|
December 5, 2024
Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
Maximilian Merz, Danai Dima, Hamza Hashmi, et al.
Blood Advances
|
August 28, 2025
Safety and Efficacy of BCMA directed Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Plasma Cell Leukemia
Gliceida M Galarza Fortuna, Lauren C Peres, Elena Nazarenko, et al.
Blood Advances
|
April 7, 2023
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions
Ajay Major, Jovian Yu, Navika Shukla, et al.
Nature Medicine
|
December 18, 2021
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nathan Hale Fowler, Michael Dickinson, Martin Dreyling, et al.
Page
of 59